For example, over-expression of NAMPT, the rate-limiting factor for NAD+ synthesis in mammalian cells, is frequently observed in a number of malignant tumors including breast, colorectal, ovarian and prostate cancers (Yaku et al., 2018; Nacarelli et al., 2020; Navas and Carnero, 2021). Here, NAMPT is linked to cancer.